MUCOCUTANEOUS AUTOIMMUNE SYNDROME FOLLOWING FLUDARABINE THERAPY FOR LOW-GRADE NON-HODGKINS-LYMPHOMA OF B-CELL TYPE (B-NHL)

Citation
J. Braess et al., MUCOCUTANEOUS AUTOIMMUNE SYNDROME FOLLOWING FLUDARABINE THERAPY FOR LOW-GRADE NON-HODGKINS-LYMPHOMA OF B-CELL TYPE (B-NHL), Annals of hematology, 75(5-6), 1997, pp. 227-230
Citations number
25
Journal title
ISSN journal
09395555
Volume
75
Issue
5-6
Year of publication
1997
Pages
227 - 230
Database
ISI
SICI code
0939-5555(1997)75:5-6<227:MASFFT>2.0.ZU;2-4
Abstract
A 40-year-old patient with low-grade B-NHL developed a generalized mac ular-papular rash following the first cycle of fludarabine treatment w hich progressed to a complete epidermal necrolysis following the secon d cycle. Clinical symptoms and the results of the direct and indirect immunofluorescence were consistent with a mucocutaneous autoimmune syn drome (pemphigus). Immunohistochemical analysis demonstrated a dense e pidermal infiltration of CD8+ lymphocytes associated with the histolog ical features of single-cell necrosis of keratinocytes. Early and aggr essive immunosuppressive treatment with steroids, cyclophosphamide, an d high-dose immunoglobulins resulted in regression of symptoms and com plete reconstitution of epidermal integrity. The malignant lymphoma ha s completely regressed. The findings suggest a fludarabine-induced def ect in immunosurveillance - resulting in the uncontrolled activation o f autoaggressive T-cell clones - as a pathogenetic mechanism of this l ife-threatening dermatological complication.